About: What is the rationale for growth hormone therapy in Turner's syndrome?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: What is the rationale for growth hormone therapy in Turner's syndrome? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1994 (uk) im Juli 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1994 (ast) scientific article published on 01 July 1994 (en)
publication date	wds:Q72682514-9820955E-6BB1-4EC1-95A0-072E0548F8B2
publication date	1994-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72682514-81C3637D-9E44-4E97-9F2E-72D293E91C7C
language of work or name	English
cites work	wds:Q72682514-000C94B6-261E-41B0-B046-14E5E3F176C5 wds:Q72682514-2A8C5F01-0BA6-4EA2-8293-C521E566E496 wds:Q72682514-2F908C74-75CB-486E-9094-5B621EDE658E wds:Q72682514-5F55FFEF-C72C-4ED9-B022-26038753704E wds:Q72682514-663BE366-B488-40CC-AE06-79CCD2478B76 wds:Q72682514-67010678-1725-49A0-8328-3E8F528F096D wds:Q72682514-715967EA-BC21-4DB2-A42C-FAD4F7DC5D4B wds:Q72682514-758A779F-1A50-455B-8E10-5CC5B54B9B40 wds:Q72682514-A3D868B0-F003-44CE-8FEB-1C11F943C188 wds:Q72682514-BB86DDC4-49A7-4F18-94D7-D152AC99C675 wds:Q72682514-CA854571-EB7F-414B-B52F-170BD4046F72 wds:Q72682514-CD08B10C-658D-48C9-9DA5-105D4F08856F wds:Q72682514-DEB792AF-C0F6-467F-B889-7CA30969E6E1
cites work	Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome Carbohydrate and lipid metabolism in Turner syndrome: effect of therapy with growth hormone, oxandrolone, and a combination of both. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study. Treatment of short normal children with growth hormone—a cautionary tale? Reduced growth hormone secretion in Turner syndrome: is body weight a key factor? GH assessment and three years' hGH therapy in girls with Turner syndrome Growth hormone, somatomedin levels and growth regulation in Turner's syndrome. Growth hormone secretory dynamics in Turner syndrome Neuroendocrine function in obesity Growth hormone secretion in pubertal age patients with Turner's syndrome. Effect of growth hormone treatment on hyperinsulinemia associated with turner syndrome Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome Dose-dependent effect of growth hormone therapy on glucose metabolism in subjects with Turner syndrome. The German Lilly Ullrich-Turner Syndrome Study Group
author name string	wds:Q72682514-2F036C66-CD80-4B68-8A19-6A5F25BF6711 wds:Q72682514-500981F3-BB8A-4283-9113-A4915F2EF87E
author name string	B Boscherini F Vaccaro
rdfs:label	What is the rationale for growth hormone therapy in Turner's syndrome? (en) What is the rationale for growth hormone therapy in Turner's syndrome? (nl)
skos:prefLabel	What is the rationale for growth hormone therapy in Turner's syndrome? (en) What is the rationale for growth hormone therapy in Turner's syndrome? (nl)
name	What is the rationale for growth hormone therapy in Turner's syndrome? (en) What is the rationale for growth hormone therapy in Turner's syndrome? (nl)
author	wds:Q72682514-08958283-5C7D-4B90-80DB-A6B6892FB9C4
author	Stefano Cianfarani
title	wds:Q72682514-F658A7B6-940E-4C93-B893-BBB0601238FB
title	What is the rationale for growth hormone therapy in Turner's syndrome? (en)
page(s)	wds:Q72682514-A1A422EC-4B0D-4FEC-A6CB-27AA491D7521
page(s)	114-115
instance of	wds:Q72682514-C14E30D6-7B73-4AA0-9EAC-E4B031E42666
instance of	scholarly article
PubMed ID	wds:Q72682514-6EC182E9-26A5-413D-A3EA-DFD5272B00B5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7912351
PubMed ID	7912351
published in	wds:Q72682514-F1403467-7061-4E38-A253-BD64868D4FB6
published in	The Lancet
issue	wds:Q72682514-B55314E4-802C-4E55-9204-BC71D4DE7B5E
volume	wds:Q72682514-0963B987-6AF0-4AB6-8718-CED50C08A5DB
issue	8915
volume	344
DOI	wds:Q72682514-0BAACEC7-319F-4364-A66F-DD4BCD28FEA4
DOI	http://dx.doi.org/10.1016/S0140-6736(94)91288-2
DOI	10.1016/S0140-6736(94)91288-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72682514
is cites work of	Does growth-hormone supplementation affect adult height in Turner's syndrome? 'Short stature in children--a questionnaire for parents': a new instrument for growth disorder-specific psychosocial adaptation in children New peptide and protein drugs The Rationale for Growth Hormone Therapy in Children with Short Stature.
is cites work of	wds:Q41127187-62076426-88BA-45C7-A110-10FA9695813F wds:Q42633580-46563699-0970-4139-A551-F773FF2FB8CF wds:Q40847909-32A6E46B-6FBF-4F20-922D-0B43339FCD7E wds:Q49538079-944700C9-FEC4-4A63-9CF3-CD26F15526AF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software